HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Nadia Belmatoug Selected Research

imiglucerase (Cerezyme)

1/2015Impact of imiglucerase supply constraint on the therapeutic management and course of disease in French patients with Gaucher disease type 1.
6/2014Effects of switching from imiglucerase to velaglucerase alfa without dose reduction nor wash out in type 1 Gaucher disease.
8/2012Characteristics of type I Gaucher disease associated with persistent thrombocytopenia after treatment with imiglucerase for 4-5 years.
5/2011The management of pregnancy in Gaucher disease.
1/2011Impact of imiglucerase on the serum glycosylated-ferritin level in Gaucher disease.
3/2010Guidelines for the restart of imiglucerase in patients with Gaucher disease: recommendations from the European Working Group on Gaucher disease.
1/2010Force majeure: therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease.
11/2009The female Gaucher patient: the impact of enzyme replacement therapy around key reproductive events (menstruation, pregnancy and menopause).
1/2002[French results of enzyme replacement therapy in Gaucher's disease].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Nadia Belmatoug Research Topics

Disease

18Gaucher Disease (Gaucher's Disease)
10/2015 - 01/2002
2Thrombocytopenia (Thrombopenia)
08/2012 - 03/2003
2Neurologic Manifestations (Neurological Manifestations)
10/2011 - 01/2002
2Spontaneous Abortion (Miscarriage)
05/2011 - 11/2009
1Tremor (Tremors)
08/2013
1Splenomegaly
08/2012
1Hepatomegaly
08/2012
1Hemolysis
06/2012
1Parkinson Disease (Parkinson's Disease)
01/2012
1Necrosis
01/2012
1Spontaneous Fractures (Pathological Fracture)
01/2012
1Body Weight (Weight, Body)
10/2011
1Flatulence
10/2011
1Abdominal Pain (Pain, Abdominal)
10/2011
1Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
10/2011
1Hemorrhage
05/2011
1Menorrhagia
11/2009
1Parkinsonian Disorders (Parkinsonism)
07/2009
1Glomerulonephritis
12/2007
1Peripheral Nervous System Diseases (PNS Diseases)
12/2007
1Fever (Fevers)
12/2007
1Arthralgia (Joint Pain)
12/2007
1Renal Insufficiency (Renal Failure)
12/2007
1Vasculitis (Vasculitides)
12/2007
1Immune System Diseases (Immune Disorders)
05/2007
1Labyrinth Diseases
05/2007
1Paraproteinemias (Monoclonal Gammopathy)
11/2006
1Histiocytosis
11/2006
1Rare Diseases (Rare Disease)
11/2006
1Ulcerative Colitis
09/2005
1Thyroiditis
09/2005
1Hashimoto Disease (Thyroiditis, Hashimoto)
09/2005
1Autoimmune Diseases (Autoimmune Disease)
09/2005
1Graves Disease (Basedow Disease)
09/2005
1Metabolic Bone Diseases (Osteopenia)
03/2003
1Congenital Abnormalities (Deformity)
03/2003
1Asthenia
03/2003
1Osteonecrosis (Kienbock's Disease)
03/2003

Drug/Important Bio-Agent (IBA)

9imiglucerase (Cerezyme)FDA Link
01/2015 - 01/2002
6Glucosylceramidase (Glucocerebrosidase)IBA
01/2014 - 01/2002
3noncerebral juvenile Gaucher diseaseIBA
01/2013 - 01/2012
2Biological Markers (Surrogate Marker)IBA
01/2014 - 01/2010
2miglustat (Zavesca)FDA Link
08/2013 - 10/2011
2tartrate-resistant acid phosphatase (TSAP)IBA
01/2010 - 03/2003
2Ferritins (Ferritin)IBA
01/2010 - 03/2003
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2010 - 03/2003
2chitotriosidaseIBA
01/2010 - 03/2003
2alglucerase (Ceredase)FDA Link
11/2009 - 01/2002
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
06/2012
1BilirubinIBA
06/2012
1Dietary Sucrose (Table Sugar)IBA
10/2011
1LactoseFDA LinkGeneric
10/2011
1MaltoseIBA
10/2011
1GlucosidasesIBA
05/2011
1glycosylated ferritinIBA
01/2011
1Levodopa (L Dopa)FDA LinkGeneric
07/2009
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
12/2007
1Adrenal Cortex Hormones (Corticosteroids)IBA
12/2007
1Immunosuppressive Agents (Immunosuppressants)IBA
12/2007
1AntibodiesIBA
05/2007
1Myelin P0 Protein (Myelin Protein Zero)IBA
05/2007
1Immunoglobulins (Immunoglobulin)IBA
11/2006
1Primary sclerosing cholangitisIBA
09/2005

Therapy/Procedure

8Enzyme Replacement Therapy
10/2015 - 01/2002
2Enzyme Therapy
08/2012 - 11/2009
1Aftercare (After-Treatment)
08/2012
1Splenectomy
01/2012